Management Credibility Analysis

Unavailable
Verified Management Score Unavailable
Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed
Verified Catalysts Unavailable
No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive
Not disclosed
Headquarters
1 WEST FIRST AVENUE, CONSHOHOCKEN, PA
Founded
Not disclosed

📈 Company Timeline

Major business events
Positive
Negative
Neutral
21 Oct 2026

Cencora, Inc. reported Operating or financial results

Cencora, Inc. filed an 8-K covering operating or financial results, Regulation FD disclosure, supporting financial statements or exhibits.

25 Sep 2026

Cencora, Inc. reported A director or senior management change or compensation event

Cencora, Inc. filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.

15 Aug 2026

Cencora, Inc. reported A director or senior management change or compensation event

Cencora, Inc. filed an 8-K covering a director or senior management change or compensation event.

12 Aug 2026

Cencora, Inc. reported Regulation FD disclosure

Cencora, Inc. filed an 8-K covering Regulation FD disclosure.

5 Aug 2026

Cencora, Inc. filed Form 10-Q

Cencora, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

Capital Structure & Financial Position

Financial strength and liquidity analysis
Cash and equivalents (USD)$2.82B
Total assets (USD)$83.81B
Shareholders' equity (USD)$3.05B
Long-term debt (USD)$11.44B
Debt due within a year (USD)$279.16M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated

Peer Comparison - Health Care

Company Price Market Cap
LLY - Eli Lilly and Company $1,276.13
Yahoo Finance 		$1.20T
JNJ - Johnson & Johnson $256.74
Yahoo Finance 		$618.71B
ABBV - AbbVie Inc. $284.80
Yahoo Finance 		$503.28B
UNH - UnitedHealth Group Incorporated $418.43
Yahoo Finance 		$375.58B
MRK - Merck & Co., Inc. $148.55
Yahoo Finance 		$366.50B

📋 Corporate Actions

Recent and upcoming corporate events
Verified Corporate Actions Unavailable
Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis
QuarterRevenue (USD)Operating incomeNet incomeDiluted EPS (USD)Filed
Q2 2026$84.75B$1.12B$763.52M$3.9410-Q · 5 Aug 2026
Q1 2026$78.36B$1.14B$1.64B$8.4010-Q · 6 May 2026
Q4 2025$85.93B$760.45M$559.65M$2.8710-Q · 4 Feb 2026
Q2 2025$80.66B$867.65M$687.40M$3.5210-Q · 6 Aug 2025
Q1 2025$75.45B$1.04B$717.87M$3.6810-Q · 7 May 2025
Q4 2024$81.49B$706.25M$488.60M$2.5010-Q · 5 Feb 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy
Target: $369.15
7.5% upside potential
📈
Strong Buy
Unavailable
👍
Buy
10
⏸️
Hold
3
📉
Sell
0
13 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 330.00–400.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments
Verified Dividend Data Unavailable
Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable
Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity
1
Oct 2026
SANCHEZ ROBERT E
Director
Grant or award
Unavailable per share
275 shares
SEC Form 4
1
Oct 2026
Krikorian Lazarus
SVP & Chief Accounting Officer
Open-market sale
$303.18 per share
986 shares
SEC Form 4
16
Sep 2026
GREENBERG LON R
Director
Open-market sale
$321.30 per share
1,280 shares
SEC Form 4
1
Sep 2026
Krikorian Lazarus
SVP & Chief Accounting Officer
Open-market sale
$325.97 per share
985 shares
SEC Form 4
24
Aug 2026
Campbell Elizabeth S
Executive Vice President
Open-market sale
$324.12 per share
11,300 shares
SEC Form 4
31
Jul 2026
NALLY DENNIS M
Director
Grant or award
$311.34 per share
113 shares
SEC Form 4
31
Jul 2026
Cooper Ellen
Director
Grant or award
$311.34 per share
97 shares
SEC Form 4
31
Jul 2026
Tyler Lauren M
Director
Grant or award
$311.34 per share
97 shares
SEC Form 4

Top Shareholders

Vanguard Group Inc
23,617,117 shares
0.947% change
12/31/2025
Blackrock, Inc.
18,213,783 shares
-8.674% change
6/30/2026
Vanguard Capital Management Llc
12,378,943 shares
0.532% change
6/30/2026
Vanguard Portfolio Management Llc
9,611,756 shares
0.223% change
6/30/2026
State Street Corp
9,273,983 shares
0.908% change
6/30/2026
T. Rowe Price Investment Management, Inc.
7,410,910 shares
17.74% change
6/30/2026
Price T Rowe Associates Inc /Md/
7,132,687 shares
-2.608% change
6/30/2026
Jpmorgan Chase & Co
5,943,657 shares
21.66% change
6/30/2026
Geode Capital Management, Llc
5,454,888 shares
-1.997% change
6/30/2026
Boston Partners
4,868,782 shares
8.61% change
6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed · 1 day ago